Immunoprecise Antibodies

Yahoo Finance • last year

New to The Street Announces TV Corporate Appearances on Episodes 479 and 480 that Start Airing on Saturday, June 17, 2023, at 3:30 PM ET

NEW YORK, June 16, 2023 (GLOBE NEWSWIRE) -- FMW Media's New to The Street announces its corporate appearances on episodes 479 and 480 on Newsmax and the FOX Business Network. Newsmax airs Episode 779 Saturday, June 17, 2023, at 3:30 PM... Full story

Yahoo Finance • 2 years ago

IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023 on March 16, 2023

The Company to host an earnings conference call via webcast VICTORIA, British Columbia, March 07, 2023--(BUSINESS WIRE)--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ: IPA), an advanced biotherapeutic research and t... Full story

Yahoo Finance • 2 years ago

10 Best Immunology Stocks to Invest In

In this article, we discuss the 10 best immunology stocks to invest in. If you want to read about some more immunology stocks, go directly to 5 Best Immunology Stocks to Invest In. Immunology is the study of the immune system of higher or... Full story

Yahoo Finance • 2 years ago

IPA’s Subsidiary Talem Therapeutics Licenses Antibodies for Three OmniChicken-Derived Programs

Under strategic collaboration, Talem, an IPA subsidiary, expands its relationship with Ligand/OmniAb, Inc., to develop three immuno-oncology programs targeting validated targets Talem intends to leverage IPA’s broad range of advanced labor... Full story

Yahoo Finance • 2 years ago

IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2023 on September 14, 2022

The Company to host an earnings conference call via webcast VICTORIA, British Columbia, September 08, 2022--(BUSINESS WIRE)--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ: IPA) (TSXV: IPA), an advanced biotherapeuti... Full story

Yahoo Finance • 2 years ago

Live Virus Assays at Ludwig-Maximilians-Universität München Confirm PolyTope’s Efficacy Against SARS-CoV-2 Variants Including BA.5

VICTORIA, British Columbia, August 29, 2022--(BUSINESS WIRE)--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ: IPA) (TSXV: IPA), a biotherapeutic research and technology company, today announced the continuing success... Full story

Yahoo Finance • 2 years ago

ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2022

The Company achieved record revenues of $19.4 million, up 8.1% from $17.9 million in fiscal year 2021 The Company achieved record revenues of $5.2 million for the three months ended April 30, 2022, an increase of 7.4% over the same period... Full story